SCHEMBL14827754

SCHEMBL14827754

NCCN1C(=O)c2ccc3c4ccc5c6c(ccc(c7ccc(c2c37)C1=O)c64)C(=O)N(CCN)C5=O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TERT O14746 8/20 0.62
▸ HEXA P06865 3/20 0.61
▸ HEXB P07686 3/20 0.61
▸ STAT3 P40763 1/20 0.58
▸ HIF1A Q16665 1/20 0.58
▸ KDM4E B2RXH2 1/20 0.50
▸ MEN1 O00255 1/20 0.50
▸ RGS12 O14924 1/20 0.50
▸ NPC1 O15118 1/20 0.50
▸ ALDH1A1 P00352 1/20 0.50
▸ LMNA P02545 1/20 0.50
▸ PABPC1 P11940 1/20 0.50
▸ HTT P42858 1/20 0.50
▸ RECQL P46063 1/20 0.50
▸ RAB9A P51151 1/20 0.50
▸ KMT2A Q03164 1/20 0.50
▸ SMN1; SMN2 Q16637 1/20 0.50
▸ KEAP1 Q14145 1/20 0.41
▸ NFE2L2 Q16236 1/20 0.41
▸ TLR9 Q9NR96 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23957091 0.86 HEXA (0.62) TERTHEXAHEXBSTAT3HIF1A
SCHEMBL19302158 0.84 TERT (0.56) TERTHEXAHEXBSTAT3HIF1A
SCHEMBL34460908 0.83 TERT (0.65) TERTHEXAHEXBSTAT3HIF1A
SCHEMBL2744278 0.81 TERT (0.71) TERTHEXAHEXBSTAT3HIF1A
SCHEMBL8680446 0.81 TERT (0.67) TERTSTAT3HIF1AKDM4EMEN1
SCHEMBL23417393 0.81 STAT3 (0.58) TERTHEXAHEXBSTAT3HIF1A
SCHEMBL12174260 0.80 HEXA (0.71) TERTHEXAHEXBSTAT3HIF1A
SCHEMBL23987359 0.80 STAT3 (0.57) TERTHEXAHEXBSTAT3HIF1A
SCHEMBL23987283 0.80 STAT3 (0.57) TERTHEXAHEXBSTAT3HIF1A
SCHEMBL23957078 0.80 STAT3 (0.57) TERTHEXAHEXBSTAT3HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130085280-A1 MATERIALS AND METHODS FOR THE PREPARATION OF ANISOTROPICALLY-ORDERED SOLIDS BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION, ON BEHALF OF THE UNIVERSITY OF NEVADA, (US) 2013-04-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130085280-A1 MATERIALS AND METHODS FOR THE PREPARATION OF ANISOTROPICALLY-ORDERED SOLIDS KIF23, VIM, INCENP TERT 910/4885HEXA 4665/4885HEXB 4736/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback